<DOC>
	<DOCNO>NCT03031847</DOCNO>
	<brief_summary>This pilot enroll 50 HF patient ( age ≥ 80 year ) undergo CRT device implantation hospital University Pittsburgh Medical Center , Duke University , Ohio State University , VA Pittsburgh Healthcare System . Patients randomize CRT-P versus CRT-D follow study end . Rates patient screening , enrollment , randomization , retention well cost care examine . The result pilot study inform design large pivotal non-inferiority trial necessary success . Patients refuse participation randomize pilot trial ask enroll prospective observational cohort . Characteristics patient choose CRT-P vs. CRT-D compare patient ' level satisfaction device decision measure .</brief_summary>
	<brief_title>Cardiac Resynchronization Elderly</brief_title>
	<detailed_description>The goal study pilot test randomize , control , non-inferiority trial compare survival quality life ( QOL ) old patient receive cardiac resynchronization therapy ( CRT ) pacemaker ( CRT-P ) versus defibrillator ( CRT-D ) therapy . This pilot enroll 50 HF patient ( age ≥ 80 year ) undergo CRT device implantation hospital University Pittsburgh Medical Center , Duke University , Ohio State University , VA Pittsburgh Healthcare System . Patients randomize CRT-P versus CRT-D follow study end . Rates patient screening , enrollment , randomization , retention well cost care examine . The result pilot study inform design large pivotal non-inferiority trial necessary success . Patients refuse participation randomize pilot trial enrol followed part prospective observational cohort . Characteristics patient choose CRT-P vs. CRT-D compare patient ' level satisfaction device decision measure .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . Age &gt; /= 80 year 2 . Left Ventricular Ejection Fraction ( LVEF ) ≤ 35 % cardiac imaging include echocardiogram , nuclear imaging , cardiac catheterization , cardiac magnetic resonance image 3 . QRS width &gt; 120 ms surface electrocardiogram 4 . New York Heart Association class II , III , ambulatory IV Heart Failure ( HF ) 5 . Patient undergo de novo CRT device implantation CRTD device changeout battery depletion 1 . Patient within 40 day acute myocardial infarction 2 . Patient within 3 month cardiac revascularization ( percutaneous coronary intervention bypass surgery ) 3 . Patient prior history cardiac arrest document sustained ventricular arrhythmia 4 . Patient expect longevity &lt; 1 year 5 . Patient optimal medical therapy HF management include tolerated βblockers , angiotensin convert enzyme inhibitor angiotensin receptor blocker , diuretic 6 . Patient plan his/her followup participate institution 7 . Patient unable unwilling sign write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>80 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>